Topic: Direct To Consumer Advertising

3 chapters across the catalog

Robert Kennedy Jr. and Donald Trump are planning to reform pharmaceutical advertising by requiring companies to list every known side effect in their commercials. Because a total ban on direct-to-consumer marketing might violate the First Amendment, this strategy forces commercials to become "two minutes of horror," making the products difficult to sell. This legal maneuver is intended to break the financial bond between Big Pharma and corporate news agencies.

Studies show that exercise is often more effective than SSRIs for treating depression, yet pharmaceutical companies continue to push drugs with significant side effects. The U.S. is one of only two nations that allow direct-to-consumer pharmaceutical advertising, which critics say misleads the public. Many antidepressants carry a black-box warning for increased suicide risk in young people.

A proposal to end direct-to-consumer pharmaceutical marketing aims to break the industry's influence over news networks, where drug companies provide 50% to 70% of advertising revenue. This financial dependency is blamed for the lack of critical coverage regarding COVID-19 vaccine safety and transmission. Removing this funding source is presented as the only way to return news agencies to serving the public interest rather than corporate sponsors.